David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.83% |
| 2 | Healthcare | 10.76% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Financials | 8.43% |
| 5 | Communication Services | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Robert Half
RHI
$4.56B
| $1.11M | ﹤0.01% |
+19,184
| New | +$1.1M |
|
2377
Estee Lauder
EL
$38B
| $1.11M | ﹤0.01% |
7,386
-128,507
| -95% | -$17.8M |
|
2378
CALL
HCA Healthcare
HCA
$92.5B
| $1.11M | ﹤0.01% |
+11,400
| New | +$1.11M |
|
|
PSB
2379
DELISTED
PS Business Parks, Inc.
PSB
| $1.1M | ﹤0.01% |
9,771
+7,309
| +297% | +$842K |
|
|
REN
2380
DELISTED
Resolute Energy Corporaton
REN
| $1.1M | ﹤0.01% |
+31,784
| New | +$1.08M |
|
2381
CALL
Leidos
LDOS
$17.2B
| $1.1M | ﹤0.01% |
16,800
-6,400
| -28% | -$422K |
|
|
LNW
2382
DELISTED
Light & Wonder
LNW
| $1.1M | ﹤0.01% |
+26,414
| New | +$1.24M |
|
2383
Teleflex
TFX
$5.88B
| $1.1M | ﹤0.01% |
+4,306
| New | +$1.13M |
|
|
WIN
2384
DELISTED
Windstream Holdings Inc
WIN
| $1.1M | ﹤0.01% |
155,552
+12,723
| +9% | +$104K |
|
2385
Ameriprise Financial
AMP
$49.5B
| $1.09M | ﹤0.01% |
7,405
+3,646
| +97% | +$595K |
|
2386
Oaktree Specialty Lending
OCSL
$1.15B
| $1.09M | ﹤0.01% |
86,677
+28,660
| +49% | +$397K |
|
2387
Five Below
FIVE
$14.2B
| $1.09M | ﹤0.01% |
+14,914
| New | +$1M |
|
2388
NovoCure
NVCR
$2.08B
| $1.09M | ﹤0.01% |
50,206
-15,719
| -24% | -$338K |
|
|
ICD
2389
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.09M | ﹤0.01% |
14,458
-88
| -0.6% | -$7.72K |
|
2390
Ionis Pharmaceuticals
IONS
$10.5B
| $1.09M | ﹤0.01% |
24,762
-54,723
| -69% | -$2.78M |
|
2391
FB Financial Corp
FBK
$2.88B
| $1.09M | ﹤0.01% |
26,811
+9,632
| +56% | +$403K |
|
|
ARR
2392
Armour Residential REIT
ARR
$2.3B
| $1.08M | ﹤0.01% |
+9,286
| New | +$1.08M |
|
|
SIR
2393
DELISTED
SELECT INCOME REIT
SIR
| $1.08M | ﹤0.01% |
126,258
+105,417
| +506% | +$963K |
|
2394
PUT
T. Rowe Price
TROW
$24B
| $1.08M | ﹤0.01% |
+10,000
| New | +$1.11M |
|
|
ADXS
2395
DELISTED
Advaxis Inc
ADXS
| $1.08M | ﹤0.01% |
42,567
+14,273
| +50% | +$533K |
|
|
BLUE
2396
DELISTED
bluebird bio
BLUE
| $1.08M | ﹤0.01% |
487
-8,165
| -94% | -$20.8M |
|
2397
Universal Electronics
UEIC
$57.9M
| $1.07M | ﹤0.01% |
20,660
+15,958
| +339% | +$776K |
|
2398
Enova International
ENVA
$5.89B
| $1.07M | ﹤0.01% |
48,687
+2,078
| +4% | +$41.8K |
|
|
CNCE
2399
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.07M | ﹤0.01% |
46,867
-56,550
| -55% | -$1.26M |
|
2400
Natural Gas Services Group
NGS
$448M
| $1.06M | ﹤0.01% |
44,653
-7,185
| -14% | -$192K |
|
Similar funds
David Shaw's Q1 2018 Portfolio in Review
As of Q1 2018, David Shaw held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- David Shaw added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- David Shaw's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- David Shaw fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- David Shaw's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- David Shaw opened 451 new positions and closed 554 in Q1 2018.
- David Shaw's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.